Samsung's 1,000 Trillion Won Investment Over 10 Years! Which Stocks Will Benefit Most? / The Real Reason JPMorgan Called KOSPI 15,000 (Samsung Electronics) Director Lee Ju-yeon

Summary

Director Lee Ju-yeon examines how the memory chip shortage is pressuring big-tech hardware firms while creating strong momentum for memory suppliers and equipment stocks. He analyzes Samsung's rumored 1,000 trillion won 10-year investment plan and its beneficiaries, warns on auto parts suppliers facing price-cut demands, and notes catch-up potential for Korean biotech as the US biotech sector hits new highs.

• Apple and Microsoft face cost pressures from memory price hikes, while memory makers and equipment stocks like Micron, Western Digital, Lam Research, and KLA benefit.
• Samsung Electronics reportedly plans a 1,000 trillion won decade-long investment; Samsung itself, Korean semiconductor equipment/materials firms, and construction companies (Samsung C&T, Samsung E&A) are direct beneficiaries.
• Hyundai Motor's union gains strike rights and is considering demanding up to 20% price cuts from parts suppliers, creating margin headwinds for auto parts stocks heavily dependent on Hyundai/Kia.
• JPMorgan upgrades KOSPI targets to 12,500–15,000, but National Pension Service selling of ~74 trillion won may cap index upside.
• US biotech ETF IBB hit an all-time high, while Korean biotech has lagged; the speaker expects a catch-up driven by rotation away from semiconductor-dominated large caps.
• Heavy semiconductor concentration leaves many stocks struggling; a shift toward small caps and previously neglected sectors is possible if the large-cap rally stalls.